CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 660351-660632 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T90021","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Seventy percent (70%) of patients (n=836) who had not been previously treated with a topical prescription anti-allergy medication treatment and 71% of previous medication users (n=2, 192) experienced at least \"moderate\" relief of itching when treated with azelastine hydrochloride."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T1100","span":{"begin":0,"end":281},"obj":"Epistemic_statement"}],"text":"Seventy percent (70%) of patients (n=836) who had not been previously treated with a topical prescription anti-allergy medication treatment and 71% of previous medication users (n=2, 192) experienced at least \"moderate\" relief of itching when treated with azelastine hydrochloride."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T249","span":{"begin":0,"end":281},"obj":"Sentence"}],"text":"Seventy percent (70%) of patients (n=836) who had not been previously treated with a topical prescription anti-allergy medication treatment and 71% of previous medication users (n=2, 192) experienced at least \"moderate\" relief of itching when treated with azelastine hydrochloride."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6100","span":{"begin":111,"end":118},"obj":"Disease"}],"attributes":[{"id":"A6100","pred":"mondo_id","subj":"T6100","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"}],"text":"Seventy percent (70%) of patients (n=836) who had not been previously treated with a topical prescription anti-allergy medication treatment and 71% of previous medication users (n=2, 192) experienced at least \"moderate\" relief of itching when treated with azelastine hydrochloride."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T3262","span":{"begin":111,"end":118},"obj":"Phenotype"},{"id":"T3263","span":{"begin":230,"end":237},"obj":"Phenotype"}],"attributes":[{"id":"A3262","pred":"hp_id","subj":"T3262","obj":"http://purl.obolibrary.org/obo/HP_0012393"},{"id":"A3263","pred":"hp_id","subj":"T3263","obj":"http://purl.obolibrary.org/obo/HP_0000989"}],"text":"Seventy percent (70%) of patients (n=836) who had not been previously treated with a topical prescription anti-allergy medication treatment and 71% of previous medication users (n=2, 192) experienced at least \"moderate\" relief of itching when treated with azelastine hydrochloride."}